3TC

lamivudine

ABC

abacavir

AIDS

acquired immunodeficiency syndrome

APV

amprenavir

ART

antiretroviral therapy

ARV

antiretroviral

AUC

area under the curve

AZT

zidovudine

CNS

central nervous system

d4T

stavudine

ddC

zalcitabine

ddI

didanosine

DLV

delavirdine

DOTS

directly observed therapy, short course

EFZ

efavirenz also known as EFV

ELISA

enzyme-linked immunosorbent assay

FDA

Food and Drug Administration (USA)

HAART

highly active antiretroviral therapy

HIV

human immunodeficiency virus

ICD

immune-complex-dissociated

IDU

injecting drug user

IDV

indinavir

LPV

lopinavir

MSF

Médecins Sans Frontières

MTCT

mother-to-child transmission

NAM

nucleoside analogue mutation

NFV

nelfinavir

NGO

nongovernmental organization

NIH

National Institutes of Health (USA)

NNRTI

non-nucleoside reverse transcriptase inhibitor

NsRTI

nucleoside analogue reverse transcriptase inhibitor

NtRTI

nucleotide analogue reverse transcriptase inhibitor

NVP

nevirapine

OI

HIV-related opportunistic infection

PCP

Pneumocystis carinii pneumonia

PCR

polymerase chain reaction

PGL

persistent generalized lymphadenopathy

PI

protease inhibitor

PPD

purified protein derivative skin test for TB

QA

quality assurance

r

low-dose ritonavir boost

RT

reverse transcriptase

RTV

ritonavir

STI

sexually transmitted infection

SQV

saquinavir

TAB

treatment advisory board

TB

tuberculosis

TDF

tenofovir disoproxil fumarate

TLC

total lymphocyte count

UN

United Nations

UNAIDS

United Nations Joint Co-sponsored. Programme on HIV/AIDS

UNGASS

United Nations General Assembly Special Session on HIV/AIDS

VCT

HIV voluntary counselling and testing

WHO

World Health Organization

ZDV

zidovudine